FQX-75293-33904
4 vaccinations
1 coded response
4 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 354 / AL
- Registered
- 2022-02-06
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-12
Dose 1 — Moderna
-
2021-03-12
Dose 2 — Moderna
-
2021-11-16
Dose 3 — Pfizer-BioNTech
-
2022-02-06
Registered in v-safe
- 2022-02-15
-
2022-05-17
Survey response — 6 months, dose 3MedDRA: Sinusitis — Feeling: GoodFree text: Sinus infectionMedDRA releases: 2024-11 · check-in free text available
-
2022-09-15
Dose 4 — Moderna
- 2022-10-03
- 2022-10-06
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-12 | Moderna | No |
| 2 | 2021-03-12 | Moderna | No |
| 3 | 2021-11-16 | Pfizer-BioNTech | No |
| 4 | 2022-09-15 | Moderna | No |
Free text
Release 11 — 6 months, dose 3
Symptoms: Sinus infection
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Sinusitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release